Chemed Corporation (NYSE:CHE) Declares Quarterly Dividend of $0.60

Chemed Corporation (NYSE:CHE) announced a quarterly dividend on Monday, May 18th. Stockholders of record on Thursday, May 28th will be paid a dividend of 0.60 per share on Tuesday, June 16th. This represents a c) annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 28th.

Chemed has increased its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 16 consecutive years. Chemed has a dividend payout ratio of 8.7% meaning its dividend is sufficiently covered by earnings. Research analysts expect Chemed to earn $25.48 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 9.4%.

Chemed Stock Up 1.7%

Shares of CHE stock opened at $441.90 on Tuesday. The firm has a fifty day moving average of $397.32 and a 200-day moving average of $425.14. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed has a 12-month low of $365.20 and a 12-month high of $583.96. The company has a market capitalization of $5.86 billion, a price-to-earnings ratio of 24.08, a P/E/G ratio of 1.63 and a beta of 0.54.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. During the same quarter in the prior year, the firm earned $5.63 earnings per share. The firm’s revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities research analysts predict that Chemed will post 22.3 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares in the company, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 3.33% of the company’s stock.

Institutional Trading of Chemed

A number of large investors have recently added to or reduced their stakes in CHE. Geneos Wealth Management Inc. lifted its stake in Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Chemed by 67.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after acquiring an additional 4,560 shares during the last quarter. Marshall Wace LLP acquired a new stake in shares of Chemed during the 2nd quarter worth about $579,000. Brown Advisory Inc. lifted its stake in shares of Chemed by 36.9% during the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock worth $267,000 after buying an additional 148 shares during the last quarter. Finally, Cerity Partners LLC lifted its stake in shares of Chemed by 237.7% during the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after buying an additional 3,133 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.